| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 26 Feb 2026 | 23 Feb 2026 |
| Indrayani Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/02/2026 ,inter alia, to consider and approve the unaudited financial results (Standalone and consolidated) for the quarter ended 31st December, 2025. Outcome of the Board Meeting held on 26th February, 2026 for approval of the Unaudited financial results (Standalone and consolidated) for the Quarter ended 31st December, 2025. (As per BSE announcement dated on :26.02.2026) | ||
| Board Meeting | 11 Dec 2025 | 5 Dec 2025 |
| Indrayani Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/12/2025 inter alia to consider and approve the unaudited financial (Standalone and Consolidated) results for the Quarter and half year ended 30th September 2025 Outcome of Board Meeting held on 11th December, 2025 for approval of unaudited (Consolidated and Standalone) financial results for the quarter and half year ended 30th September, 2025 (As Per BSE Announcement Dated on: 11/12/2025) | ||
| Board Meeting | 14 Nov 2025 | 13 Nov 2025 |
| Indrayani Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve Unaudited financial (Standalone and Consolidated) results for the Quarter and half year ended 30th September 2025. Indrayani Biotech Ltd has informed BSE that the meeting of the Board of Directors inter alia, to consider and approve unaudited financial results (standalone and consolidated) for quarter and Half year ended 30th September 2025 has been postponed. | ||
| Board Meeting | 30 Aug 2025 | 26 Aug 2025 |
| Indrayani Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/08/2025 inter alia to consider and approve INDRAYANI BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/08/2025 inter alia to consider and approve the following items of business: 1.Notice of the 33rd Annual General Meeting of the company.2.Disinvestment from Material Subsidiary - Dindigul Farm Product Limited. 3.Reclassification from Promoter status to Public shareholder status at Dindigul Farm Product Limited.4.Rescindment Of Resolution Passed at the 32nd Annual General Meeting for Increasing the Authorized Share Capital.5.Increase of Authorised share capital of the Company from Rs.65 crores to Rs.85 crores comprising 8.50 crores equity shares of Rs. 10/- each (Eight Crores and Fifty Lakhs) and consequential amendment of the capital clause in the Memorandum of Association of the Company.6.Appointment of Mr. Swaminathan (DIN: 02481041) as Whole-Time Director.7.Appointment of Mr. Singarababu Indirakumar (DIN: 00892351) as Whole-Time Director. Outcome of the Board Meeting held on 30th August, 2025 with regard to upcoming AGM (As per BSE Announcement Dated on 30/08/2025) | ||
| Board Meeting | 14 Aug 2025 | 11 Aug 2025 |
| Quarterly Results-Indrayani Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 ,inter alia, to consider and approve i. The unaudited Financial Results of the Company for the Quarter ended June 30, 2025, along with the Limited Review Report of the Auditors. ii. Any other business with the permission of the Chair. Adoption of unaudited Standalone and Consolidated financial results for the Quarter ending June25 (As Per BSE Announcement Dated on: 14/08/2025) Revised outcome of unaudited Standalone and consolidated financial results for the Quarter ended 30-06-2025. (As Per BSE Announcement Dated on:21.08.2025) | ||
| Board Meeting | 13 Jun 2025 | 27 May 2025 |
| Indrayani Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/06/2025 inter alia to consider and approve audited financial results (standalone and consolidated) for quarter and year ended 31st March 2025 The Company, vide its announcement dated 27th May 2025, informed that the Board meeting for approving the said results would be convened by 9th June 2025, after the due date, since the consolidation of results from our subsidiaries combined along with completion of internal and external audit processes of the company are taking more time than estimated to complete the preparation of the results. However, the Company understands that the finalisation of audited financial results (standalone and consolidated) for the quarter and year ended 31st March 2025 requires some more time and hence the Board meeting for approval of said results planned for today is adjourned to 12th June 2025. (As per BSE Announcement Dated on 09/06/2025) Audited Standalone Financial Results for the quarter and year ended 31st March 2025 along with Audit report Outcome of Board meeting held on 12th June 2025 (As Per BSE Announcement dated on 12.06.2025) Audited consolidated financial results for the quarter and year ended 31st March 2025 along with report of statutory auditors. Outcome of the Board meeting held on 13th June 2025 (As Per BSE Announcement dated on 13.06.2025) | ||
| Board Meeting | 3 Apr 2025 | 27 Mar 2025 |
| Indrayani Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/04/2025 inter alia to consider and approve amendments in the terms of Rights issue of equity shares of the Company Announcement with respect to the amendments to the terms of Rights issue of equity shares as partly paid up equity shares instead of fully paid up equity shares, as approved by the Board of Directors on 3rd April 2025. Outcome of Board meeting held on 3rd April 2024 is attached herewith. (As Per BSE Announcement Dated on: 03/04/2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
